disulfiram and taurine

disulfiram has been researched along with taurine in 89 studies

Research

Studies (89)

TimeframeStudies, this research(%)All Research%
pre-19901 (1.12)18.7374
1990's10 (11.24)18.2507
2000's45 (50.56)29.6817
2010's32 (35.96)24.3611
2020's1 (1.12)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Goodwin, DW; Liskow, BI1
Schuckit, MA1
Swift, RM1
Aeby, F; Besson, J; Kasas, A; Lehert, P; Potgieter, A1
Gache, P; Siegrist, G1
Chabac, S; Durbin, P; Houin, G; Hulot, T; Potgieter, A; Saivin, S1
Carey, TS; Crews, FT; Garbutt, JC; Lohr, KN; West, SL1
Malerich, JA1
Rueff, B1
Mason, B1
Carey, TS; Crews, FT; Garbutt, JC; Jackman, AM; Lohr, KN; Lux, LJ; Tolleson-Rinehart, S; West, SL1
Gordon, SM1
Anton, RF1
Yarborough, WH1
Fideli, LP; Lejoyeux, M1
Graham, R; Whelan, G; Wodak, AD1
Mason, BJ1
Bransberger, P; Crosse, S; Kranzler, HR; Mark, TL; Poole, VH; Song, X1
Lee, TH1
Kenna, GA; McGeary, JE; Swift, RM1
Baltieri, DA; Castro, LA1
Berglund, M; Johnson, BA; Lesch, OM; Litten, RZ; Mann, K; Swift, RM; Willenbring, ML1
Buonopane, A; Petrakis, IL1
Williams, SH1
Egli, M; Heilig, M1
Jung, YC; Namkoong, K1
Leeman, RF; Starosta, AN; Volpicelli, JR1
Balester-Mouret, S; Batel, P1
Kranzler, HR1
Bleich, S; Hillemacher, T; Kornhuber, J1
Roesner, S; Soyka, M1
Ducharme, LJ; Knudsen, HK; Roman, PM1
Diehl, A; Mann, K1
Mørland, J1
Quertemont, E; Tambour, S1
Swift, R1
Peterson, AM1
McDonough, KP1
Brunette, MF; Drake, RE; Green, AI; Noordsy, DL1
Brunette, MF; Green, AI; Noordsy, DL; O'Keefe, C1
Johnson, BA1
Kuehn, BM1
Berglund, M; Gorelick, D; Hesselbrock, V; Johnson, BA; Kranzler, HR; Möller, HJ; Soyka, M1
Blanc, F; Perney, P; Rigole, H1
Kassed, CA; Kranzler, HR; Levit, KR; Mark, TL; Vandivort-Warren, R1
Garbutt, JC1
Diehl, A; Herre, H; Kiefer, F; Mann, K; Mutschler, J; Vollmert, C1
Chand, PK; Thirthalli, J1
de Silva, V; Hanwella, R1
Olive, MF1
Bowe, T; Harris, AH; Humphreys, KN; Kivlahan, DR1
Chalk, M; Gastfriend, DR; Kranzler, HR; Mark, TL; Montejano, LB1
Abraham, AJ; Knudsen, HK; Roman, PM1
Baser, O; Chalk, M; Gastfriend, DR; Rawson, R1
Krogh, J; Nordentoft, M; Petrov, I1
Bujarski, S; Courtney, KE; Ray, LA; Squeglia, LM1
Spanagel, R; Vengeliene, V1
Book, SW; Miller, PM; Stewart, SH1
Clark, DB1
Kuźniar-Placek, J; Panasiuk, L; Szponar, J1
Bowe, T; Ellerbe, L; Gordon, AJ; Hagedorn, H; Harris, AHS; Kivlahan, D; Lembke, A; Oliva, E; Reeder, RN; Trafton, JA1
O'Connor, PG; O'Malley, SS1
Krishnan-Sarin, S; Krystal, JH; O'Malley, S1
Franck, J; Jayaram-Lindström, N1
Kranzler, HR; Zindel, LR1
Liang, J; Olsen, RW1
Friedmann, PD; Park, TW1
Borro, P; Leone, S; Testino, G1
Agabio, R; Franconi, F; Gessa, GL; Pani, PP; Preti, A1
Gofman, AG; Ponizovskiy, PA1
Helton, SG; Lohoff, FW1
Cicin-Šain, L; Kovak-Mufić, A; Marušić, S; Matošić, A; Vidrih, B1
Salisbury-Afshar, E1
Bramness, JG; Mann, K; Wurst, FM1
Bowe, T; Christopher, M; Finlay, AK; Gidwani, R; Hagedorn, H; Harris, AH; Kay, C; Nevedal, A; Rosen, C1
Brewer, C; Skinner, M; Streel, E1
Goh, ET; Morgan, MY1
Manolopoulos, VG; Ragia, G1
Ashcroft, DM; Owens, L; Pirmohamed, M; Thompson, A; van Staa, TP1
Lyon, J1
Bonnet, U; Dembski, N; Niederhofer, A; Niederhofer, E; Nyhuis, PW; Scherbaum, N; Schifano, F; Specka, M; Tenbergen, M1
Kranzler, HR; Soyka, M1
Gorczyca, P; Piegza, M; Pudlo, R; Stokłosa, I; Stokłosa, M; Więckiewicz, G1

Reviews

50 review(s) available for disulfiram and taurine

ArticleYear
Pharmacological treatment of alcohol intoxication, withdrawal and dependence: a critical review.
    Journal of studies on alcohol, 1987, Volume: 48, Issue:4

    Topics: Alcohol Deterrents; Alcoholic Intoxication; Alcoholism; Antidepressive Agents, Tricyclic; Bromocriptine; Cyanamide; Disulfiram; Ethanol; Fenfluramine; Humans; Lithium; Nitroimidazoles; Substance Withdrawal Syndrome; Sympathomimetics; Taurine; Tranquilizing Agents; Zimeldine

1987
Recent developments in the pharmacotherapy of alcohol dependence.
    Journal of consulting and clinical psychology, 1996, Volume: 64, Issue:4

    Topics: Acamprosate; Alcohol Deterrents; Anti-Anxiety Agents; Buspirone; Disulfiram; Ethanol; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Substance-Related Disorders; Taurine

1996
The pharmacological treatment of alcohol dependence.
    Medicine and health, Rhode Island, 1997, Volume: 80, Issue:3

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Comorbidity; Depression; Disulfiram; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Taurine

1997
Clinical pharmacokinetics of acamprosate.
    Clinical pharmacokinetics, 1998, Volume: 35, Issue:5

    Topics: Acamprosate; Age Factors; Alcohol Deterrents; Animals; Desipramine; Diazepam; Disulfiram; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Food-Drug Interactions; Humans; Imipramine; Psychotropic Drugs; Sex Characteristics; Taurine

1998
Pharmacological treatment of alcohol dependence: a review of the evidence.
    JAMA, 1999, Apr-14, Volume: 281, Issue:14

    Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Lithium; Naltrexone; Narcotic Antagonists; Serotonin Agents; Taurine

1999
[Evaluation of drug treatment of primary alcoholism].
    La Revue du praticien, 1999, Feb-15, Volume: 49, Issue:4

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Follow-Up Studies; Humans; Naltrexone; Self-Help Groups; Taurine; Treatment Outcome

1999
Pharmacotherapy for alcohol dependence.
    Evidence report/technology assessment (Summary), 1999, Issue:3

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Health Policy; Humans; Lithium; Naltrexone; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Serotonin Agents; Taurine; United States

1999
Pharmacologic approaches to the management of alcoholism.
    The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 20

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Behavior, Addictive; Clinical Trials as Topic; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Taurine; Treatment Outcome

2001
[Long-term treatment of alcohol dependance].
    Gastroenterologie clinique et biologique, 2002, Volume: 26, Issue:5 Suppl

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Combined Modality Therapy; Disulfiram; Family Therapy; Humans; Long-Term Care; Naltrexone; Psychotherapy; Self-Help Groups; Social Support; Social Work; Taurine; Treatment Outcome

2002
New pharmacotherapies for alcohol dependence.
    The Medical journal of Australia, 2002, Jul-15, Volume: 177, Issue:2

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Australia; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Self-Help Groups; Taurine; Treatment Outcome

2002
Acamprosate.
    Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism, 2003, Volume: 16

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Double-Blind Method; Humans; Multicenter Studies as Topic; Naltrexone; Randomized Controlled Trials as Topic; Taurine; Treatment Outcome

2003
Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2004, Nov-01, Volume: 61, Issue:21

    Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcohol-Related Disorders; Animals; Clinical Trials as Topic; Disulfiram; Excitatory Amino Acid Antagonists; Humans; Naltrexone; Narcotic Antagonists; Taurine

2004
Pharmacotherapy of alcohol use disorders.
    Substance use & misuse, 2005, Volume: 40, Issue:13-14

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Amitriptyline; Antidepressive Agents, Tricyclic; Comorbidity; Disulfiram; Dopamine; Drug Interactions; Ethanol; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Male; Mental Disorders; Naltrexone; Narcotics; Serotonin; Taurine

2005
Medications for treating alcohol dependence.
    American family physician, 2005, Nov-01, Volume: 72, Issue:9

    Topics: Acamprosate; Adult; Aged; Alcohol Deterrents; Alcohol-Related Disorders; Alcoholism; Disulfiram; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Naltrexone; Patient Compliance; Randomized Controlled Trials as Topic; Serotonin Agents; Taurine; Treatment Outcome

2005
Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.
    Pharmacology & therapeutics, 2006, Volume: 111, Issue:3

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Baclofen; Corticotropin-Releasing Hormone; Disease Models, Animal; Disulfiram; Fructose; Humans; Naltrexone; Neuropeptide Y; Nociceptin; Ondansetron; Opioid Peptides; Receptor, Cannabinoid, CB1; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Taurine; Topiramate

2006
Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention.
    Yonsei medical journal, 2006, Apr-30, Volume: 47, Issue:2

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; gamma-Aminobutyric Acid; Glutamine; Humans; Models, Biological; Models, Neurological; N-Methylaspartate; Naltrexone; Narcotic Antagonists; Neurons; Polymorphism, Genetic; Receptors, Opioid, mu; Recurrence; Taurine

2006
[Neurobiological mechanisms and pharmacological treatment options for alcohol craving].
    Fortschritte der Neurologie-Psychiatrie, 2007, Volume: 75, Issue:1

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Neurosecretory Systems; Neurotransmitter Agents; Receptors, Glutamate; Taurine

2007
New pharmacological approaches for the treatment of alcoholism.
    Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:17

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Carbamazepine; Depression; Disease Models, Animal; Disulfiram; Fructose; Humans; Naltrexone; Secondary Prevention; Taurine; Topiramate

2006
Trends in the adoption of medications for alcohol dependence.
    Journal of clinical psychopharmacology, 2006, Volume: 26 Suppl 1

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Longitudinal Studies; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors; Taurine; United States

2006
[Pharmacological relapse prevention in alcohol and tobacco dependence].
    Der Internist, 2007, Volume: 48, Issue:1

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Clinical Trials as Topic; Combined Modality Therapy; Disulfiram; Humans; Naltrexone; Nicotine; Psychotherapy; Secondary Prevention; Smoking Cessation; Substance Withdrawal Syndrome; Taurine; Tobacco Use Disorder

2007
Preclinical and clinical pharmacology of alcohol dependence.
    Fundamental & clinical pharmacology, 2007, Volume: 21, Issue:1

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Disulfiram; Dopamine; GABA Modulators; Glutamic Acid; Humans; Naltrexone; Narcotic Antagonists; Serotonin; Taurine

2007
Emerging approaches to managing alcohol dependence.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, Mar-01, Volume: 64, Issue:5 Suppl 3

    Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Behavior Therapy; Brain; Disulfiram; Drug Therapy, Combination; Ethanol; Humans; Naltrexone; Taurine

2007
Improving adherence in patients with alcohol dependence: a new role for pharmacists.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, Mar-01, Volume: 64, Issue:5 Suppl 3

    Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Behavior Therapy; Disulfiram; Humans; Naltrexone; Patient Compliance; Pharmacists; Professional Role; Taurine; Treatment Refusal

2007
Substance abuse and schizophrenia: pharmacotherapeutic intervention.
    Journal of substance abuse treatment, 2008, Volume: 34, Issue:1

    Topics: Acamprosate; Alcohol Deterrents; Antipsychotic Agents; Clozapine; Disulfiram; Drug Interactions; Humans; Naltrexone; Narcotics; Schizophrenia; Substance-Related Disorders; Taurine

2008
Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.
    Biochemical pharmacology, 2008, Jan-01, Volume: 75, Issue:1

    Topics: Acamprosate; Alcoholism; Animals; Baclofen; Disulfiram; Fructose; Humans; Naltrexone; Ondansetron; Receptors, N-Methyl-D-Aspartate; Ritanserin; Selective Serotonin Reuptake Inhibitors; Taurine; Topiramate

2008
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2008, Volume: 9, Issue:1

    Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Biological Psychiatry; Carbamazepine; Disulfiram; Fructose; Health Planning Guidelines; Humans; Naltrexone; Ondansetron; Societies, Scientific; Substance-Related Disorders; Taurine; Topiramate

2008
[Alcohol dependence: diagnosis and treatment].
    La Revue de medecine interne, 2008, Volume: 29, Issue:4

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Cognitive Behavioral Therapy; Disulfiram; Humans; Motivation; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome; Taurine

2008
The state of pharmacotherapy for the treatment of alcohol dependence.
    Journal of substance abuse treatment, 2009, Volume: 36, Issue:1

    Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Baclofen; Delayed-Action Preparations; Disulfiram; Fructose; Humans; Medication Adherence; Naltrexone; Taurine; Temperance; Topiramate

2009
[Recent results in relaps prevention of alcoholism with Disulfiram].
    Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 2008, Volume: 22, Issue:4

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Aldehyde Dehydrogenase; Combined Modality Therapy; Disulfiram; Drug Interactions; Drug Therapy, Combination; Germany; Humans; Metabolic Clearance Rate; Motivation; Naltrexone; Randomized Controlled Trials as Topic; Secondary Prevention; Taurine

2008
The implications of medication development in the treatment of substance use disorders in developing countries.
    Current opinion in psychiatry, 2009, Volume: 22, Issue:3

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Buprenorphine; Comorbidity; Developing Countries; Disulfiram; HIV Infections; Humans; Methadone; Narcotic Antagonists; Prevalence; Public Policy; Substance Abuse, Intravenous; Substance-Related Disorders; Taurine

2009
[Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review].
    Ugeskrift for laeger, 2011, Nov-28, Volume: 173, Issue:48

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Evidence-Based Medicine; Humans; Naltrexone; Taurine; Treatment Outcome

2011
New pharmacological treatment strategies for relapse prevention.
    Current topics in behavioral neurosciences, 2013, Volume: 13

    Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Animals; Disulfiram; Drugs, Investigational; History, 18th Century; History, 21st Century; Humans; Naltrexone; Receptors, N-Methyl-D-Aspartate; Secondary Prevention; Taurine

2013
Medical treatment of alcohol dependence: a systematic review.
    International journal of psychiatry in medicine, 2011, Volume: 42, Issue:3

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Fructose; Humans; Naltrexone; Narcotic Antagonists; Off-Label Use; Taurine; Topiramate; Treatment Outcome

2011
[The patient with an alcohol abuse problem family doctor practice].
    Przeglad lekarski, 2012, Volume: 69, Issue:8

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Family Practice; Humans; Poland; Practice Patterns, Physicians'; Taurine

2012
Medications for unhealthy alcohol use: across the spectrum.
    Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism, 2011, Volume: 33, Issue:4

    Topics: Acamprosate; Alcohol Drinking; Alcoholism; Animals; Disulfiram; Dopamine Agents; Fructose; Humans; Naltrexone; Selective Serotonin Reuptake Inhibitors; Taurine; Topiramate

2011
Treatment implications: using neuroscience to guide the development of new pharmacotherapies for alcoholism.
    Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism, 2008, Volume: 31, Issue:4

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Brain Chemistry; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Taurine; Treatment Outcome

2008
Pharmacotherapy for alcohol dependence: status of current treatments.
    Current opinion in neurobiology, 2013, Volume: 23, Issue:4

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Clinical Trials as Topic; Disulfiram; Humans; Multicenter Studies as Topic; Naltrexone; Narcotic Antagonists; Taurine

2013
Pharmacotherapy of alcohol use disorders: seventy-five years of progress.
    Journal of studies on alcohol and drugs. Supplement, 2014, Volume: 75 Suppl 17

    Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Disulfiram; Fructose; Humans; Hypnotics and Sedatives; Narcotic Antagonists; Pharmacogenetics; Taurine; Topiramate

2014
Alcohol use disorders and current pharmacological therapies: the role of GABA(A) receptors.
    Acta pharmacologica Sinica, 2014, Volume: 35, Issue:8

    Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Benzodiazepines; Disulfiram; Ethanol; Fructose; Humans; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Plant Preparations; Receptors, GABA-A; Taurine; Topiramate

2014
Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders.
    Rhode Island medical journal (2013), 2014, Oct-01, Volume: 97, Issue:10

    Topics: Acamprosate; Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Directive Counseling; Disulfiram; Humans; Methadone; Naltrexone; Narcotic Antagonists; Practice Patterns, Physicians'; Substance-Related Disorders; Taurine; United States

2014
Treatment of alcohol dependence: recent progress and reduction of consumption.
    Minerva medica, 2014, Volume: 105, Issue:6

    Topics: Acamprosate; Age of Onset; Alcohol Deterrents; Alcohol-Related Disorders; Alcoholism; Binge Drinking; Contraindications; Craving; Disulfiram; Drugs, Investigational; Europe; Humans; Meta-Analysis as Topic; Multicenter Studies as Topic; Naltrexone; Neurotransmitter Agents; Randomized Controlled Trials as Topic; Sodium Oxybate; Taurine

2014
Efficacy of Medications Approved for the Treatment of Alcohol Dependence and Alcohol Withdrawal Syndrome in Female Patients: A Descriptive Review.
    European addiction research, 2016, Volume: 22, Issue:1

    Topics: Acamprosate; Alcohol Deterrents; Alcohol Withdrawal Delirium; Alcoholism; Anticonvulsants; Benzodiazepines; Disulfiram; Female; Humans; Male; Naltrexone; Sex Factors; Taurine; Treatment Outcome

2016
[Depression in alcohol addicted patients].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2015, Volume: 115, Issue:7

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Comorbidity; Depressive Disorder; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Taurine

2015
Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders.
    Psychiatry research, 2015, Dec-15, Volume: 230, Issue:2

    Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Anxiety Disorders; Comorbidity; Depressive Disorder, Major; Disulfiram; Fructose; Humans; Naltrexone; Pharmacogenetics; Precision Medicine; Taurine; Topiramate; United States

2015
NEUROBIOLOGICAL BASES OF ALCOHOL ADDICTION.
    Acta clinica Croatica, 2016, Volume: 55, Issue:1

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Brain; Disulfiram; Dopamine; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Minisatellite Repeats; Monoamine Oxidase; Naltrexone; Narcotic Antagonists; Neuropeptide Y; Norepinephrine; Ondansetron; Polymorphism, Genetic; Serotonin; Synaptic Transmission; Taurine

2016
Supervised Disulfiram's Superior Effectiveness in Alcoholism Treatment: Ethical, Methodological, and Psychological Aspects.
    Alcohol and alcoholism (Oxford, Oxfordshire), 2017, Mar-09, Volume: 52, Issue:2

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Bioethical Issues; Disulfiram; Humans; Naltrexone; Taurine

2017
Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore.
    Alimentary pharmacology & therapeutics, 2017, Volume: 45, Issue:7

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Baclofen; Disulfiram; Drug Combinations; Fructose; Humans; Naltrexone; Polymorphism, Single Nucleotide; Pyridoxine; Pyrrolidonecarboxylic Acid; Taurine; Topiramate; Treatment Outcome

2017
Personalized Medicine of Alcohol Addiction: Pharmacogenomics and Beyond.
    Current pharmaceutical biotechnology, 2017, Volume: 18, Issue:3

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone; Pharmacogenetics; Polymorphism, Genetic; Precision Medicine; Taurine

2017
Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review.
    JAMA, 2018, 08-28, Volume: 320, Issue:8

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Counseling; Disulfiram; Humans; Naltrexone; Taurine

2018
Medications for the Treatment of Alcohol Dependence-Current State of Knowledge and Future Perspectives from a Public Health Perspective.
    International journal of environmental research and public health, 2023, 01-19, Volume: 20, Issue:3

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Pharmaceutical Preparations; Public Health; Taurine

2023

Trials

2 trial(s) available for disulfiram and taurine

ArticleYear
Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study.
    Alcoholism, clinical and experimental research, 1998, Volume: 22, Issue:3

    Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Disulfiram; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Long-Term Care; Male; Middle Aged; Taurine; Temperance; Treatment Outcome

1998
Effectiveness of Psychoanalytic-Interactional Group Therapy vs. Behavioral Group Therapy in Routine Outpatient Treatment of Alcohol-Dependent Patients.
    Substance use & misuse, 2018, 02-23, Volume: 53, Issue:3

    Topics: Acamprosate; Alcoholism; Cognitive Behavioral Therapy; Combined Modality Therapy; Disulfiram; Female; Humans; Male; Middle Aged; Naltrexone; Outpatients; Psychoanalytic Therapy; Psychotherapy, Group; Recurrence; Secondary Prevention; Taurine; Treatment Outcome

2018

Other Studies

37 other study(ies) available for disulfiram and taurine

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
[Medical treatment of alcohol dependence].
    Revue medicale de la Suisse romande, 1998, Volume: 118, Issue:9

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Taurine

1998
Prevention of relapse in alcohol dependence.
    American family physician, 1999, Apr-01, Volume: 59, Issue:7

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Behavior Therapy; Disulfiram; Family; Humans; Naltrexone; Narcotic Antagonists; Recurrence; Self-Help Groups; Taurine

1999
Medical allies against alcoholism.
    Health news (Waltham, Mass.), 1999, Jun-25, Volume: 5, Issue:8

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone; Taurine

1999
Does the alcoholic's remedy come in a pill?
    Behavioral healthcare tomorrow, 2001, Volume: 10, Issue:4

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Excitatory Amino Acid Antagonists; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Ondansetron; Patient Compliance; Serotonin Antagonists; Social Support; Taurine; United States

2001
Addiction medicine for the primary care physician.
    The Journal of the Oklahoma State Medical Association, 2001, Volume: 94, Issue:11

    Topics: Acamprosate; Alcohol Deterrents; Alcoholics Anonymous; Alcoholism; Antidepressive Agents, Tricyclic; Disulfiram; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Primary Health Care; Recurrence; Risk Factors; Severity of Illness Index; Substance-Related Disorders; Taurine; Treatment Outcome

2001
Drug treatments for alcoholism.
    The Harvard mental health letter, 2002, Volume: 18, Issue:10

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone; Substance Withdrawal Syndrome; Taurine

2002
Physicians' opinions about medications to treat alcoholism.
    Addiction (Abingdon, England), 2003, Volume: 98, Issue:5

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Attitude of Health Personnel; Clinical Competence; Disulfiram; Health Care Surveys; Humans; Naltrexone; Narcotic Antagonists; Taurine; Treatment Outcome

2003
Ask the doctor. I need to quit drinking, but don't think I can do it on my own. Can I use a drug like Antabuse even though I have heart disease?
    Harvard heart letter : from Harvard Medical School, 2004, Volume: 15, Issue:2

    Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Contraindications; Disulfiram; Heart Diseases; Humans; Naltrexone; Taurine

2004
Acamprosate campral for alcoholism.
    The Medical letter on drugs and therapeutics, 2005, Jan-03, Volume: 47, Issue:1199

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Diarrhea; Disulfiram; Drug Therapy, Combination; Humans; Naltrexone; Taurine

2005
[The pharmacologic treatment of the alcohol dependence].
    Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2004, Volume: 26 Suppl 1

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Taurine

2004
Challenges and opportunities for medications development in alcoholism: an international perspective on collaborations between academia and industry.
    Alcoholism, clinical and experimental research, 2005, Volume: 29, Issue:8

    Topics: Academies and Institutes; Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Cooperative Behavior; Cross-Cultural Comparison; Disulfiram; Drug Approval; Drug Industry; Drugs, Investigational; Evidence-Based Medicine; Humans; Interprofessional Relations; Naltrexone; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Taurine

2005
Drug treatment for alcoholism today.
    The Harvard mental health letter, 2005, Volume: 22, Issue:1

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Disulfiram; Fructose; Humans; Naltrexone; Substance Withdrawal Syndrome; Taurine; Topiramate

2005
New alcohol abuse drugs emerging. Anti-craving meds are finally here to treat alcohol dependence, recognized as a disease of the brain.
    Health news (Waltham, Mass.), 2005, Volume: 11, Issue:12

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone; Taurine

2005
The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders.
    Journal of psychiatric practice, 2006, Volume: 12, Issue:2

    Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Attitude to Health; Disulfiram; Humans; Male; Naltrexone; Narcotic Antagonists; Patient Compliance; Psychological Theory; Psychology; Psychotherapy; Taurine

2006
[Maintaining abstinence after alcohol detoxification].
    La Revue du praticien, 2006, May-31, Volume: 56, Issue:10

    Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Ambulatory Care; Behavior Therapy; Clinical Protocols; Cognitive Behavioral Therapy; Disulfiram; Follow-Up Studies; Humans; Naltrexone; Patient Care Planning; Psychoanalytic Therapy; Psychotherapy, Group; Psychotropic Drugs; Social Support; Taurine; Temperance

2006
Extended-release intramuscular naltrexone: a viewpoint by Henry R Kranzler.
    Drugs, 2006, Volume: 66, Issue:13

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Delayed-Action Preparations; Disulfiram; Humans; Injections, Intramuscular; Naltrexone; Narcotic Antagonists; Taurine

2006
[Drugs against alcohol abuse].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2006, Dec-14, Volume: 126, Issue:24

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Drug Evaluation; Humans; Naltrexone; Narcotic Antagonists; Taurine; Treatment Outcome

2006
Alcohol dependence and pharmacologic treatment. Introduction.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, Mar-01, Volume: 64, Issue:5 Suppl 3

    Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Disulfiram; Humans; Naltrexone; Taurine; United States

2007
Schizophrenia and co-occurring substance use disorder.
    The American journal of psychiatry, 2007, Volume: 164, Issue:3

    Topics: Acamprosate; Adult; Alcohol-Related Disorders; Antipsychotic Agents; Comorbidity; Diagnosis, Dual (Psychiatry); Disulfiram; Humans; Ill-Housed Persons; Male; Naltrexone; Schizophrenia; Substance-Related Disorders; Taurine

2007
New therapies for alcohol dependence open options for office-based treatment.
    JAMA, 2007, Dec-05, Volume: 298, Issue:21

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Behavior Therapy; Disulfiram; Family Practice; Fructose; Humans; Naltrexone; Taurine; Topiramate

2007
Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty.
    Drug and alcohol dependence, 2009, Jan-01, Volume: 99, Issue:1-3

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Buprenorphine; Delayed-Action Preparations; Disulfiram; Drug Costs; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Humans; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Osteopathic Medicine; Physicians; Physicians, Family; Psychiatry; Taurine; United States

2009
Treatment of alcohol dependence.
    The Ceylon medical journal, 2009, Volume: 54, Issue:2

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Fructose; Humans; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Taurine; Topiramate; Vitamins

2009
Alcohol dependence: after the withdrawal phase. Long-term abstinence: better health and psychosocial status. Psychosocial support for a chronic disorder. Some drugs are useful adjuncts to medical support.
    Prescrire international, 2009, Volume: 18, Issue:103

    Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcohol-Related Disorders; Alcoholics; Alcoholism; Anticonvulsants; Baclofen; Clinical Trials as Topic; Combined Modality Therapy; Disulfiram; France; Fructose; Health Status; Humans; Naltrexone; Psychotherapy; Randomized Controlled Trials as Topic; Secondary Prevention; Self-Help Groups; Social Support; Taurine; Temperance; Topiramate; Treatment Outcome

2009
Pharmacotherapies for alcoholism: the old and the new.
    CNS & neurological disorders drug targets, 2010, Volume: 9, Issue:1

    Topics: Acamprosate; Alcohol Deterrents; Alcohol-Induced Disorders, Nervous System; Alcoholism; Animals; Disease Models, Animal; Disulfiram; Drug Design; Humans; Naltrexone; Narcotic Antagonists; Neuropeptides; Neuropharmacology; Neurotransmitter Agents; Receptors, Neurotransmitter; Taurine

2010
Pharmacotherapy of alcohol use disorders in the Veterans Health Administration.
    Psychiatric services (Washington, D.C.), 2010, Volume: 61, Issue:4

    Topics: Acamprosate; Administration, Oral; Adult; Age Factors; Alcohol Deterrents; Alcoholism; Ambulatory Care; Comorbidity; Delayed-Action Preparations; Disulfiram; Drug Therapy, Combination; Drug Utilization; Female; Humans; Injections, Intramuscular; Male; Mental Disorders; Middle Aged; Naltrexone; Selective Serotonin Reuptake Inhibitors; Sex Factors; Substance Abuse Treatment Centers; Taurine; United States; Veterans

2010
Comparison of healthcare utilization among patients treated with alcoholism medications.
    The American journal of managed care, 2010, Volume: 16, Issue:12

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Delayed-Action Preparations; Disulfiram; Female; Health Services; Health Status Indicators; Humans; Inpatients; Insurance Claim Review; Male; Middle Aged; Naltrexone; Narcotics; Propensity Score; Retrospective Studies; Taurine; United States

2010
Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation.
    Addictive behaviors, 2011, Volume: 36, Issue:6

    Topics: Acamprosate; Alcohol Deterrents; Buprenorphine; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Patient Education as Topic; Substance Abuse Treatment Centers; Substance-Related Disorders; Taurine; United States

2011
Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.
    The American journal of managed care, 2011, Volume: 17 Suppl 8

    Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Chi-Square Distribution; Databases, Factual; Disulfiram; Female; Health Care Costs; Health Services; Humans; Male; Naltrexone; Narcotic Antagonists; Propensity Score; Retrospective Studies; Statistics as Topic; Statistics, Nonparametric; Taurine; Treatment Outcome; United States

2011
Pharmacogenetics of alcoholism: a clinical neuroscience perspective.
    Pharmacogenomics, 2012, Volume: 13, Issue:2

    Topics: Acamprosate; Alcoholism; Alleles; Disulfiram; Genetic Markers; Humans; Naltrexone; Narcotic Antagonists; Polymorphism, Single Nucleotide; Precision Medicine; Receptors, Opioid, mu; Serotonin Plasma Membrane Transport Proteins; Taurine

2012
Pharmacotherapy for adolescent alcohol use disorder.
    CNS drugs, 2012, Jul-01, Volume: 26, Issue:7

    Topics: Acamprosate; Adolescent; Alcohol-Related Disorders; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Central Nervous System Stimulants; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Disulfiram; Humans; Naltrexone; Substance Withdrawal Syndrome; Substance-Related Disorders; Taurine

2012
Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers.
    Psychological services, 2013, Volume: 10, Issue:4

    Topics: Acamprosate; Adult; Aged; Alcohol Deterrents; Alcoholism; Attitude of Health Personnel; Disulfiram; Drug Utilization; Female; Formularies as Topic; Health Care Surveys; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Preference; Practice Guidelines as Topic; Practice Patterns, Physicians'; Qualitative Research; Taurine; United States; United States Department of Veterans Affairs; Veterans Health

2013
Pharmacotherapy for Adults with Alcohol Use Disorder.
    American family physician, 2016, Jul-15, Volume: 94, Issue:2

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Taurine

2016
Marketing Status and Perceived Efficacy of Drugs for Supporting Abstinence and Reducing Alcohol Intake in Alcohol Use Disorders: A Survey among European Federation of Addiction Societies in Europe.
    European addiction research, 2016, Volume: 22, Issue:6

    Topics: Acamprosate; Alcohol Abstinence; Alcohol Deterrents; Alcohol-Related Disorders; Disulfiram; Europe; Humans; Marketing; Naltrexone; Narcotic Antagonists; Perception; Practice Guidelines as Topic; Societies, Medical; Surveys and Questionnaires; Taurine; Treatment Outcome

2016
Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness.
    Addiction science & clinical practice, 2016, 09-15, Volume: 11, Issue:1

    Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol-Related Disorders; Disulfiram; Female; Fructose; Humans; Male; Middle Aged; Naltrexone; Patient Compliance; Taurine; Topiramate; United States; United States Department of Veterans Affairs; Veterans; Young Adult

2016
Drug therapy for alcohol dependence in primary care in the UK: A Clinical Practice Research Datalink study.
    PloS one, 2017, Volume: 12, Issue:3

    Topics: Acamprosate; Adolescent; Adult; Aged; Alcohol Deterrents; Alcoholism; Cohort Studies; Disulfiram; Female; Humans; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Primary Health Care; Sex Factors; Socioeconomic Factors; Taurine; Time Factors; Treatment Outcome; United Kingdom; Young Adult

2017
More Treatments on Deck for Alcohol Use Disorder.
    JAMA, 2017, Jun-13, Volume: 317, Issue:22

    Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Amines; Baclofen; Cyclohexanecarboxylic Acids; Cytidine Diphosphate Choline; Disulfiram; Drug Repositioning; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Mifepristone; Naltrexone; National Institute on Alcohol Abuse and Alcoholism (U.S.); Off-Label Use; Patient Acceptance of Health Care; Taurine; Topiramate; United States; Varenicline

2017